Jeremy Skillington on Poolbeg's Rare Disease Strategy \u0026 New Developments

(8:32)

Poolbeg Pharma's Allmond hopes to replicate Amryt success

(9:30)

Interview with CEO, Jeremy Skillington from Poolbeg Pharma

(12:57)

Scientific Advisor at Poolbeg Pharma

(4:1econd)

VP of Regulatory Affairs of Poolbeg Pharma

(3:24)

Poolbeg Pharma \

(8:7)

Poolbeg Pharma makes virus \

(4:26)

Poolbeg Pharma (POLB) Investor presentation - June 2024

(42:53)

POOLBEG PHARMA PLC - Company Update

(51:35)

Poolbeg Pharma and Silk Road Therapeutics announce strategic collaboration on novel orphan drug

(8:31)

DESTINY PHARMA PLC - XF product pipeline

(2:6:37)

Poolbeg Pharma says research confirms $10B plus opportunity for POLB 001 in cancer immunotherapies

(5:45)

Poolbeg Pharma's POLB 001 immuno-modulator II receives fully-granted patent from US Patent Office

(4:9)

Poolbeg Pharma advancing portfolio of products and platforms which is 'driving value'

(6:40)

Open Orphan's CEO talks through name change and a first half 'full of highlights'

(7:11)

Accesso Technology Group sees \

(5:9)

Dr. Shai Shen-Orr: Human Immune Monitoring Coming of Age

(52:14)

Multiple Sclerosis breakthrough - FSD Pharma

(6:4)

Non-Executive Director Professor Luke O'Niell on POLB 001 \u0026 AI

(4:)

POOLBEG PHARMA PLC - Company Presentation

(45:36)

Poolbeg Pharma's new NED looking at \

(4:53)

Professor Luke O'Neill background and reasons for joining Poolbeg Pharma

(1:8)

Poolbeg Pharma #POLB - CEO Jeremy Skillington talks to Alan Green

(16:36)

Poolbeg Pharma and CytoReason talk up unique AI opportunity to advance flu treatments

(8:10)

Poolbeg Pharma's Jeremy Skillington presents new deal with AI in developing new RSV drugs

(4:28)

Immense promise for cashed up Poolbeg Pharma

(11:50)

Jeremy Skillington Poolbeg Pharma Overview

(1:53)

Elfen Lied - Lilium Full - High Quality

(3:2)

Poolbeg Pharma #POLB August 2023 - CEO Jeremy Skillington talks to Alan Green

(12:45)

Poolbeg Pharma wins first non-dilutive grant funding

(3:28)